Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P100
Near historical high
vs 2Y Ago
27x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 220.95% |
| Q3 2025 | 26.69% |
| Q2 2025 | 23.83% |
| Q1 2025 | -65.02% |
| Q4 2024 | 24.00% |
| Q3 2024 | -18.38% |
| Q2 2024 | 27.47% |
| Q1 2024 | -34.83% |
| Q4 2023 | 8.20% |
| Q3 2023 | 7.17% |
| Q2 2023 | 8.18% |
| Q1 2023 | -31.43% |
| Q4 2022 | -12.17% |
| Q3 2022 | -10.67% |
| Q2 2022 | 15.65% |
| Q1 2022 | 14.81% |
| Q4 2021 | -18.04% |
| Q3 2021 | -9.35% |
| Q2 2021 | -23.35% |
| Q1 2021 | -8.73% |
| Q4 2020 | -18.71% |
| Q3 2020 | -40.50% |
| Q2 2020 | 10.27% |
| Q1 2020 | -17.14% |
| Q4 2019 | -50.45% |
| Q3 2019 | -97228.61% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |